by Dr Robbins | Jul 30, 2019 | Migraine
The article by Depre and colleagues demonstrated that the new migraine preventive erenumab may be safe for stable angina patients. Loading... Taking too long? Reload document | Open in new...
by Dr Robbins | Jul 13, 2019 | Migraine
In this cross-sectional observational study with 256 students, researchers explored whether a later high school start time was correlated with lower migraine frequency in high school students with migraine. Using social media, participants were recruited nationally....
by Dr Robbins | Jul 12, 2019 | Headache Drugs, Migraine
This is a new letter to the editor that I wrote, in the journal Headache; these newer CGRP meds are marvelous for many patients, but the true side effect profile is just evolving: (LETTER FROM THE JOURNAL HEADACHE, JULY, 2019: LAWRENCE ROBBINS,M.D.) Erenumab, the...
by Dr Robbins | Jun 6, 2019 | Headache Drugs, Migraine
Dr Robbins & CGRP Part I We were privileged to have Dr. Lawrence Robbins doing a Facebook Live Chat in our group on May 21, 2019. Dr Robbins talked about the CGRP Medications one year after the first medication was FDA approved, and answered questions about how...
by Dr Robbins | Jun 1, 2019 | Migraine
Dr Larry Robbins from the Robbins Headache Clinic answers questions in a Facebook Live Chat for the CGRP & Migraine Community Group. FAQs from migraine patients about the CGRP medications one year after the first one was FDA approved, and information on how...